Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tables, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

  Recent Press Releases:

4/29/2008	ELITE PHARMACEUTICALS APPOINTS CHIEF SCIENTIFIC OFFICER
3/31/2008	Elite Pharmaceuticals, Inc. Reports Opioid Abuse-Resistant Products Gaining Momentum Elite Provides Update on Company’s Progress and Projected Milestones
3/3/2008	Elite Pharmaceuticals, Inc. to Present at the Susquehanna Financial Healthcare Conference
2/14/2008	Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine’s 24th Annual Meeting
1/23/2008	Elite Pharmaceuticals, Inc. Retains The Global Consulting Group as Strategic Communications Advisors